
NUCIEN PHARMA: Guangzhou Qianyuan plans to reduce its holdings by no more than 3% of shares

According to the Zhitong Finance APP, NUCIEN PHARMA announced that due to funding needs, Guangzhou Qianyuan plans to reduce its holdings of the company's shares through centralized bidding and block trading. This reduction plan will be carried out within three months after the disclosure date of this reduction plan, with a total reduction of no more than 8.232 million shares, accounting for no more than 3% of the company's total share capital
According to the announcement from Zhitong Finance APP, NUCIEN PHARMA (688189.SH) announced that due to funding needs, Guangzhou Qianyuan plans to reduce its holdings of the company's shares through centralized bidding and block trading. This reduction plan will be carried out within three months after the disclosure date of this reduction plan, with a total reduction of no more than 8.232 million shares, accounting for no more than 3% of the company's total share capital

